Table 1.
Class | Substrate | ABC transporter(s) | Relevance in pregnancy and neonatal life | References |
---|---|---|---|---|
Anti-epileptic | Phenobarbital | P-gp | First-line treatment for most neonatal seizures | [39, 40] |
Lamotrigine | P-gp | Safe for use during pregnancy (26,416,395) | [39, 41] | |
Phenytoin |
P-gp Mrp1 |
Second line treatment for neonatal seizures | [39, 40, 42] | |
Topiramate | P-gp | Second-generation AED, sometimes used to treat refractory neonatal seizures (Sandoval 2019) | [39, 40] | |
Anti-HIV | Zidovudine |
P-gp BCRP Mrp4 |
Indicated for treatment of neonates with HIV | [43, 44] |
Ritonavir |
P-gp Mrp1, Mrp2 |
Infants and children, combined with Lopinavir | [42, 45] | |
AZT |
BCRP Mrp4 |
Safe for use in pregnant women and their infants in combination w/Zidovudine | [42, 46] | |
Analgesics | Morphine | P-gp | Management for post-operative pain | [39, 47] |
Methadone | P-gp | Neonatal abstinence syndrome; therapeutic treatment for opiate abuse during pregnancy | [47, 48] | |
Anti-cancer | Doxorubicine |
P-gp BCRP Mrp1, Mrp2, Mrp6 |
[42] | |
Mitoxantrone |
P-gp BCRP |
[42] | ||
Daunorubicin |
P-gp BCRP Mrp1, Mrp6 |
[42] | ||
Methotrexate |
P-gp Mrp1, Mrp2, Mrp3, Mrp4 |
[42] | ||
Anti-depresssants | Amitryptiline | P-gp | Increased rate of cardiac abnormalities when taken during pregnancy | [42, 49] |
Doxepin | P-gp | No increased incidence of neonatal cardiac abnormalities when used during pregnancy | [42, 49] | |
Other substrates | Verapamil |
P-gp Mrp1 |
Calcium channel blocker; a competitive inhibitor of P-gp | [42] |
Cyclosporin A |
P-gp Mrp1 |
Immunosuppressants; also a competitive inhibitor of P-gp | [42] |